European Journal of Cancer
VerifiedJournal
The European Journal of Cancer is a peer-reviewed medical journal devoted to cancer research on experimental oncology, clinical oncology (medical, paediatric, radiation, surgical), and on cancer epidemiology and prevention. It is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European Cancer Organisation (ECCO), the European Association for Cancer Research (EACR) and the European Society of Breast Cancer Specialists (EUSOMA). The editor-in-chief is Alexander M. M. Eggermont . Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | France |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
| Frequency | Monthly |
| Accepts contributed content | Yes |
Recent Articles
Search ArticlesResponse to letter Re: COVID-19 Vaccination Before Immune Checkpoint Inhibitor Initiation and the Overall Survival of Patients with Advanced Cancer: A cohort study
Get full text access Log in, subscribe or purchase for full access. References 1. Liu & Zhao, letter in this issue. 2. Jee, J. ∙ Zhang, J. ∙ Lavery, J.A. ... Deconvolving SARS-CoV-2 mRNA vaccine impact on immunotherapy-related survival Cancer Discov. 2026 Jun 22; 3. Grippin, A.J. ∙ Marconi, C. ∙ Copling, S. ... SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade Nature. 2025; 647(8089):488-497 4.
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2− metastatic breast cancer treated with CDK4/6 inhibitors
1Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Rome, 00128, Italy 2Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, Rome, 00128, Italy 3Medical Oncology Unit, Santa Rosa Hospital, Department of Oncology and Hematology, Strada Sammartinese snc, Viterbo, 01100, Italy 4Division of Medical Oncology, “G.
Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
Key words Primary central nervous system lymphoma (PCNSL) long term survival, leukoencephalopathy C5R regimen high dose methotrexate, whole brain radiotherapy second cancers Get full text access Log in, subscribe or purchase for full access. References 1. Ferreri, A.J.M. ∙ Calimeri, T. ∙ Cwynarski, K. ... Primary central nervous system lymphoma Nat Rev Dis Primers. 2023; 9:29 2. Ferreri, A.J.M. ∙ Illerhaus, G. ∙ Doorduijn, J.K. ...
nxmLocal therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma
List of Abbreviations RM-NPC (recurrent or metastatic nasopharyngeal carcinoma) ICI (immune checkpoint inhibitor therapy) LOCI (local therapy combined with ICI) PSM (propensity score matching) IPTW (Inverse probability of treatment weighting. SMD, standardized mean differences.
Development of an age specific EORTC questionnaire to assess the Health-Related Quality of Life (HRQOL) of children with cancer aged 8-14 years – a mixed-methods content elicitation Phase I & II EORTC QLG study
Keywords health-related quality of life childhood and adolescent cancer concept elicitation patient reported outcome measures patient involvement Get full text access Log in, subscribe or purchase for full access. References 1. American Cancer Society Cancer Facts & Figures 2025 American Cancer Society, Atlanta, 2025 2. Erdmann, F. ∙ Frederiksen, L.E. ∙ Bonaventure, A. ... Childhood cancer: survival, treatment modalities, late effects and improvements over time Cancer epidemiology. 2021; 71, 101733 3.
Lenvatinib plus pembrolizumab for the Treatment of Patients with Non-BRAF mutated Anaplastic Thyroid Cancer: A single center, phase 2 clinical trial,
Keywords undifferentiated thyroid cancer targeted therapy immunotherapy immune checkpoint inhibitor multikinase inhibitor tyrosine kinase inhibitor BRAF wild-type Get full text access Log in, subscribe or purchase for full access. References 1. Wang, J.R. ∙ Montierth, M. ∙ Xu, L. ... Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma JCO Precis Oncol. 2022;, e2100504 2. Subbiah, V. ∙ Kreitman, R.J. ∙ Wainberg, Z.A. ...
Letter Re: COVID-19 vaccination before immune checkpoint inhibitor initiation and the overall survival of patients with advanced cancer: A cohort study
Get full text access Log in, subscribe or purchase for full access. Data availability No new data were generated or analysed for this Correspondence. References 1. Heudel, P.E. ∙ Avrillon, V. ∙ Mastroianni, B. ... COVID-19 vaccination before immune checkpoint inhibitor initiation and the overall survival of patients with advanced cancer: A cohort study Eur J Cancer. 2026; 241, 116770 2. Grippin, A.J. ∙ Marconi, C. ∙ Copling, S. ...
Diagnostic Regulatory Pathways are an Underrecognized Bottleneck in Precision Oncology Clinical Trials: Real-World Evidence Across Europe
Keywords Precision medicine oncology personalized medicine companion diagnostics IVDR clinical trial activation drug-diagnostic co-development regulatory science Get full text access Log in, subscribe or purchase for full access. References 1. Siegel, R.L. ∙ Miller, K.D. ∙ Jemal, Fuchs H.E. A. Cancer Statistics, 2023 CA Cancer J Clin. 2023; 73(1):17-48 2. Sant, M. ... Patterns of care and survival for lung cancer: results of European population-based high-resolution studies Front Epidemiol. 2023; 6.
Older Adults With Resectable Gastric Cancer Undergoing Perioperative Chemotherapy or Preoperative Chemoradiotherapy Plus Perioperative Chemotherapy: A Secondary Analysis of the AGITG TOPGEAR Phase III Trial
Keywords Stomach Neoplasms Chemoradiotherapy Radiotherapy Postoperative Complications Treatment Outcome Survival Analysis Geriatric oncology 1 Introduction Gastric cancer is the fifth most common malignancy worldwide and the fourth leading cause of cancer-related death [1]. In patients with localized, resectable disease, curative treatment relies on surgery combined with perioperative systemic therapy.
Immune remodelling and molecular profiling of progressive brain metastases following cranial radiotherapy
KEYWORDS Brain metastasis progression epigenetic signatures genetic profile tumor immune microenvironment immune reprogramming Get full text access Log in, subscribe or purchase for full access. REFERENCES 1. Steindl, A. ∙ Brunner, T.J. ∙ Heimbach, K. ... Changing characteristics, treatment approaches and survival of patients with brain metastasis: data from six thousand and thirty-one individuals over an observation period of 30 years European Journal of Cancer. 2022; 162:170-181 2.